Avon Technologies Plc’s (LSE:AVON) 2025 full-year investor update highlights a year of stronger-than-expected financial results, record order intake, and solid operational momentum as the group nears completion of its multi-year transformation programme. Revenue grew 14% with operating profit up 31% to $40.3 million, supported by improved productivity, lower scrap rates, and stronger inventory turns driven by the company’s proprietary Strengthened System. The order book rose 16% to an all-time high of $263 million, providing robust visibility into FY26 across helmets, respirators, naval protection, and integrated CBRN solutions. Avon Protection delivered significant growth in international demand and margins, while Team Wendy advanced helmet production, expanded military and law-enforcement sales, and continued to improve profitability following the US factory consolidation. The group reported strong EBITDA conversion, 90% cash conversion, ROIC of 18.6%, and net leverage below 0.9x despite increased R&D investment and capital expenditure. Management reaffirmed its growth strategy focused on innovation, new product development, enhanced manufacturing efficiency, and selective M&A to complement organic expansion. With defence spending rising globally and demand increasing for advanced respiratory protection, rebreathers, and next-generation helmets, Avon Technologies expects high-single-digit revenue growth in FY26 and operating margins within its 14–16% target range. The company has now met or exceeded nearly all of its 2027 financial targets ahead of schedule, underpinned by a strong order pipeline, expanding market share, and continued operational excellence.

Record PLC (LSE: REC), a leading specialist in currency and asset management, reported record-high assets under management (AUM) of $110.3 billion for the half year to September, reflecting continued strategic progress despite a 9% decline in revenue following the loss of legacy mandates. The Group maintained tight cost control with operating costs down 4%, preserving a robust balance sheet and sustaining an interim dividend of 2.15 pence per share. Record is advancing its transformation toward higher-margin, recurring-revenue streams through its expanding private markets and infrastructure investment platforms, including the first deployment from the €1.1 billion Record Infrastructure Equity Fund and the upcoming $1 billion Sharia-compliant supply chain finance fund. Private markets, though representing less than 1% of total AUM, now generate 16% of revenue, demonstrating the strong profitability of this business line. Core risk management and absolute return strategies remain stable, while the fast-growing Solutions for Asset Managers platform achieved a 40% increase in AUM to $17.2 billion, driven by institutional demand for tailored FX and interest rate hedging solutions. With a clear growth strategy focused on diversification, innovation, and operational excellence, Record PLC is evolving into a more resilient and profitable asset manager, supported by a strong order book, expanding EBITDA margins, and a robust pipeline across private credit, infrastructure, and emerging markets, positioning the Group for sustained value creation and long-term shareholder returns.

Atalaya Mining Copper S.A. (LSE:ATYM) delivered a strong third quarter, reporting solid copper production in line with full-year guidance and reinforcing its position as a leading low-cost European copper producer. The company achieved EBITDA of approximately €31 million and operating cash flow of €42 million, generating €24 million in free cash flow after €18 million in investments. Year-to-date EBITDA reached around €140 million, with free cash flow exceeding €60 million and net profit rising to €71 million, driven by favorable copper prices, higher silver by-product credits, and disciplined cost control. Cash costs averaged $2.33/lb and all-in sustaining costs remained below $2.90/lb, reflecting resilient margins and operational efficiency. Supported by a strong balance sheet with €93 million in working capital and a growing net cash position, Atalaya continues to deliver shareholder value through consistent dividends and strategic growth. Key development projects, including the low-capex Touro mine and ongoing exploration at Masa Valverde, San Dionisio, and in Sweden, are expected to double copper production capacity within three years. Amid tightening global supply and rising long-term demand from electrification and AI-driven infrastructure, Atalaya’s robust financial results, disciplined capital allocation, and ESG-focused management team position the company for sustainable growth and enhanced investor returns.

Canadian General Investments Limited (LSE:CGI), one of North America’s oldest closed-end equity funds, delivered an investor update highlighting its long-term record of outperforming the Toronto Stock Exchange Index and delivering consistent dividend growth. Founded in 1930 and listed on both the Toronto and London Stock Exchanges, CGI manages approximately $1.9 billion in assets with $1.2 billion in unrealized gains and maintains modest leverage of about 10%. The fund invests primarily in Canadian equities with up to 25% allocated to U.S. holdings, providing diversified exposure across sectors beyond the country’s traditional concentration in financials and energy. Operating as an investment corporation, CGI benefits from tax-efficient distributions that combine income and capital gains dividends, enabling 12 consecutive years of dividend increases between 3–8% annually. Its disciplined, long-term investment approach emphasizes quality compounders such as Celestica, Nvidia, and Franco-Nevada, alongside strategic exposure to high-growth sectors including technology, gold, and uranium—key drivers of future market expansion. Despite temporary NAV softness due to a gold-led market rally, CGI continues to outperform over 10-, 25-, and 50-year periods, reflecting strong portfolio fundamentals and risk-adjusted returns. With a fully aligned ownership structure and a proven history of capital growth, rising income, and tax efficiency, Canadian General Investments remains a compelling opportunity for investors seeking steady performance, diversification, and long-term value creation in the Canadian equity market.

AB Dynamics PLC (ABDP:AIM) reported a robust FY2025 performance, marking another year of solid financial and strategic progress. Operating profit and EPS both rose 15%, slightly ahead of upgraded expectations, supported by a 3% increase in revenue and a 210-basis-point expansion in operating margin to 20.3%. The group’s strong cash generation, with cash conversion of 106%, lifted year-end net cash to £41.4 million, even after £8.1 million of investment in acquisitions and capital projects. The recently acquired Bolab was successfully integrated, contributing positively to the testing products segment. Key operational improvements and an enhanced revenue mix underpinned margin gains, though management cautioned the mix benefit is unlikely to recur in FY2026. The order book stood at £32 million, providing strong trading momentum into FY2026. The company reiterated its medium-term growth plan to double revenue and triple operating profit, targeting sustained organic revenue growth of 10% annually, a margin above 20%, and continued 100% cash conversion. AB Dynamics continues to benefit from long-term regulatory and structural drivers in vehicle testing, safety, and simulation markets, underpinned by increasing complexity in autonomous and ADAS development. Its OEM- and powertrain-agnostic model, diversified customer base, and global reach provide resilience against macroeconomic disruption. The board remains confident in delivering FY2026 adjusted operating profit in line with expectations, maintaining a progressive dividend policy with a proposed 20% increase, and leveraging its strong balance sheet for both organic and inorganic growth opportunities.

Abingdon Health PLC (ABDX:AIM) delivered a confident investor presentation outlining strong operational and financial progress for FY2025, highlighting results in line with broker forecasts and significant H2 momentum driven by new contract wins and post-period deal flow. CFO Tom Hayes reported revenue growth supported by acquisitions of IVDeology and CS Life Sciences, which expanded the company’s regulatory capabilities, and a recent £3.2 million fundraising aimed at accelerating US manufacturing and supporting larger CDMO contracts. Executive Chairman Chris Hand emphasized Abingdon’s evolution into a full-service diagnostics partner, combining lateral flow development, regulatory expertise, and performance evaluation through its expanded UK sites and new Madison, Wisconsin facility. The company’s U.S. subsidiary, led by co-founder Chris Yates, has rapidly gained traction with six active contracts and growing demand for domestic production. Product innovation remains central to Abingdon’s strategy, including the AppDX AI-powered smartphone reader, eco-friendly red seaweed-based test cassettes, and partnerships for infectious disease diagnostics such as malaria and avian flu. Management reiterated that momentum has continued into FY2026, with market forecasts from Zeus projecting breakeven at adjusted EBITDA level and cash flow positivity during calendar 2026. The leadership team underlined their focus on scaling growth while maintaining shareholder alignment through disciplined capital deployment and a robust international expansion plan.

Cambridge Nutritional Sciences PLC (CNSL:AIM) delivered its H1 FY2026 interim results, outlining both challenges and strategic progress in advancing its personalised nutrition diagnostics business. Interim CEO James Cooper and CFO Ajay Patel reported H1 revenues of £3.9 million, below expectations due to weaker sales in Asia, the Americas, and parts of Europe, though UK and India markets saw notable growth, the latter up 33% year-on-year. Despite revenue pressure, gross margins improved to 67.7%, reflecting operational efficiencies and process improvements, while adjusted EBITDA remained positive at £0.1 million, supported by cost control. The company ended the half with £3.6 million in cash. Management highlighted ongoing sales team restructuring, a new customer success function, and investments in automation, IVDR compliance, and product innovation such as the Gut Detective test. Looking ahead, CNS expects FY2026 revenue to be below FY2025 levels but anticipates further gross margin gains and a positive adjusted EBITDA for the full year. The company targets mid-term revenue growth to £12 million and long-term ambitions of £20 million, underpinned by geographic expansion, strengthened sales execution, and scalable infrastructure. Management reaffirmed its commitment to shareholder value creation through disciplined cost management, margin enhancement, and sustained product leadership in food sensitivity and gut health diagnostics.

Savannah Resources PLC (SAV:AIM) delivered a highly positive investor update, with CEO Emanuel Proença confirming the company’s latest fundraising round was oversubscribed, securing US$12 million (£9.2 million) plus additional retail participation. The new capital strengthens Savannah’s balance sheet to around US$26 million (£20 million), enabling the company to progress its Definitive Feasibility Study (DFS) for the Barroso Lithium Project in Portugal and advance early-stage construction and financing preparations. Institutional investor participation has nearly doubled since June, with notable backing from AMG Critical Materials, Ruvuma, and Tourism Investments, alongside growing Portuguese and Spanish institutional interest. The oversubscription underscores market confidence in Savannah’s strategic positioning within Europe’s lithium value chain. Funds will accelerate DFS completion, front-end engineering and design (FEED), and project finance activities targeted for finalisation by late summer next year. Savannah also plans to acquire the Aldeia concession, expanding its resource base to an estimated 39 million tonnes, with additional exploration potential of 35–62 million tonnes. With an enhanced management and technical team, including experienced hires from Australia and Portugal, the company is preparing for the transition from development to production. Savannah reaffirmed that its cost estimates remain within expected parameters despite inflationary pressures and is actively engaging strategic and financial partners, including European and Japanese entities, to support project funding. This update highlights Savannah’s steady progress toward Final Investment Decision (FID) and its goal to establish Europe’s largest lithium spodumene operation, reinforcing its role in advancing regional employment, community development, and Europe’s energy transition.

Cap-XX Limited (CPX:AIM) delivered a robust investor update highlighting a transformational FY2025 marked by disciplined execution and revenue growth amid global headwinds. CEO Lars Stegmann reported an 8% year-on-year revenue increase to approximately AUD 5 million, supported by a strong 1.2 book-to-bill ratio and an encouraging start to FY2026 with bookings up 25% and revenue up 12%. The company remains debt-free with total available cash of AUD 3.3 million, including an anticipated R&D tax credit. Operationally, Cap-XX has successfully integrated a new CRM and manufacturing system powered by Microsoft Power BI, providing real-time global visibility and efficiency improvements. Production output at its Seven Hills facility has been optimized with new SMT (surface mount technology) equipment and leadership, reducing lead times and boosting customer trust. The company’s distribution network expanded significantly through partnerships with Walden Electronics (master distributor), Farnell, and RS Components, enhancing market access and customer reach. CFO Anthony Guarna highlighted FY2025 as a turnaround year with revenue up 7.6%, margins steady at 29.7%, and EBITDA loss reduced by 40.5%, demonstrating strong cost control and improving cash stewardship. Looking ahead, Cap-XX expects continued progress toward profitability, supported by a balanced multi-sector focus across mobile, industrial, IoT, aerospace, and healthcare markets. Collaboration with partner Shorter remains central to developing next-generation SMT products for the aerospace and defence sectors. Management reiterated its confidence in achieving sustainable growth in FY2026 and beyond, with strengthened operations, diversified product lines, and robust IP protection underpinning future expansion.

Incanthera PLC (INC:LSE) delivered a strong investor update at its 2025 Annual General Meeting, highlighting continued momentum in dermatology innovation and commercial performance following the August 2025 launch of its Skin + Cell skincare range. All AGM resolutions were approved, including auditor reappointment and board re-elections, reinforcing shareholder confidence in the company’s growth strategy. Management reported robust sales trends, high customer retention, and accelerating repeat purchase rates, supported by positive consumer testimonials and growing traction across international markets, particularly Asia. The Skin + Cell brand has demonstrated early profitability within the direct-to-consumer (DTC) model, leveraging targeted digital marketing and data-driven engagement to enhance margins and brand visibility. Strategic priorities include expanding distribution into retail and wholesale channels, launching new product variants such as an SPF aerosol, and developing non-dilutive funding options to sustain growth without equity dilution. Management reaffirmed operational efficiency through its lean “virtual company” structure, which minimizes overhead while maximizing scalability. With strong early adoption, disciplined licensing plans, and a well-defined commercialization roadmap, Incanthera is positioning itself for sustained revenue growth and shareholder value creation in 2026 and beyond.

Solaris Resources Inc (SLS:TSX) delivered a landmark investor presentation highlighting the scale and economic strength of its Warintza copper project in Ecuador, positioning it as a tier-one, multi-generational asset in global copper supply. CEO and President Mathew Rowlinson emphasized the project’s simplicity, strategic flexibility, and robust social licence, supported by a $200 million Royal Gold financing package to fund the feasibility study. The recently completed pre-feasibility study (PFS) reported a 312% increase in measured and indicated resources over 2024, with reserves supporting a 22-year mine life and the potential to extend operations by a further 30 years. The project’s low strip ratio of 0.53:1 and all-in sustaining cash costs of $1.07/lb over the first 15 years place it among the world’s lowest-cost producers, generating an expected post-tax NPV8 of $4.6 billion and 26% IRR. Average annual production is forecast at 300,000 tonnes copper equivalent over the first five years and 240,000 tonnes over 15 years, with a total life-of-mine EBITDA of $25 billion. COO Javier Toro outlined Warintza’s optimized, environmentally encapsulated design and strong infrastructure access via ports, roads, and power grids. The project benefits from Ecuador’s stable fiscal regime and growing government support for mining. The company aims to secure final environmental approval by year-end, with feasibility completion and early works slated for 2026, followed by construction in 2027. With its clean, high-grade copper concentrate, strong social partnerships, and first-quartile cost structure, Solaris is advancing one of the world’s most competitive copper developments, offering material long-term value to shareholders.

Dotdigital Group Plc (AIM:DOTD) reported strong FY2025 results, highlighting consistent revenue growth, margin strength, and strategic expansion across global markets. The company achieved 94% recurring or repeating revenues, underscoring the resilience of its SaaS model, with over 90% gross margins in its core CXDP operations and a 32% adjusted EBITDA margin. Free cash flow reached £13.9 million, supported by disciplined cost management and a debt-free balance sheet. Annual recurring revenue (ARR) grew at a 13% CAGR over four years, driven by robust organic performance and strategic acquisitions such as Social Snowball, which expands Dotdigital’s footprint in the high-growth influencer marketing sector. International revenues now account for 33% of total group revenue, up 20% year-on-year, with notable progress in the US and APAC regions. Continued investment of 12–13% of revenue in R&D has strengthened AI-led personalization, automation, and loyalty solutions that drive marketing ROI and customer engagement. Dotdigital’s all-in-one marketing platform integrates email, SMS, WhatsApp, and web personalization to unify customer data, improve segmentation, and enable cross-channel optimization. Supported by over 1,000 global partners, the company’s scalable model continues to attract enterprise and mid-market clients seeking higher-value marketing automation. With a focus on innovation, recurring revenue growth, and international expansion, Dotdigital remains well-positioned to deliver on its FY2026 outlook. The Group’s strong order book, progressive dividend policy, and active M&A strategy reinforce its commitment to shareholder value, sustainable profitability, and long-term growth within the digital marketing and automation industry.

Cindrigo Holdings Limited (CINH:LSE) delivered an investor presentation outlining its clean energy growth strategy and operational progress following its recent London Stock Exchange main market listing. CEO Lars Guldstrand emphasised Cindrigo’s focus on base-load renewable power generation, targeting 1GW of installed capacity across Europe. The company operates two key assets — a 110MW forestry waste-to-energy plant in Finland expected to commence operations by year-end 2025, and three large geothermal licence areas in Germany’s Upper Rhine Valley with 300MW potential, including heat, power, and lithium extraction. Management detailed strong German government support for geothermal projects, including up to 90% drilling insurance and long-term tariff guarantees. CFO Dag highlighted that Cindrigo’s LSE listing and Green Economy Mark recognition provide a solid platform for future institutional funding and expansion. Near-term milestones include finalising customer offtake in Finland, securing two additional German project extensions, and initiating drilling in 2026. The company’s five-year outlook targets steady cash flow from Finland, staged geothermal expansion in Germany, and selective acquisition of complementary renewable assets. Management reiterated confidence in Cindrigo’s strong asset base, experienced leadership, and ability to deliver shareholder value through disciplined project execution and sustainable energy development.

International Biotechnology Trust PLC (IBT:LSE) reported strong performance for the year ended 31 August 2025, marking its fourth consecutive fiscal year of outperformance versus the NASDAQ Biotech Index. The fund achieved a total NAV per share return of 0.7% and a 3.8% return from its quoted portfolio, compared with a 6% decline in the benchmark. The trust maintained a 4.7% dividend yield and narrowed its share price discount from 11.3% to 8.9%, supported by over 3 million shares repurchased during the period. Co-lead fund managers Elsa and Marek highlighted five M&A transactions in the fiscal year and nine in the calendar year, reinforcing optimism for continued consolidation in the biotech sector. They noted that the reduction of management fees on the quoted portfolio to 65 basis points further enhances shareholder value. The managers discussed strategic gearing during sector lows in April, capitalising on recovery momentum and M&A activity. Approximately half the portfolio is invested in clinically de-risked assets, with an increased focus on rare diseases and smaller-cap biotech companies offering attractive valuations and acquisition potential. IBT’s diversified, actively managed portfolio is designed to capture upside in late-stage biotech while mitigating binary event risk. The trust’s positive outlook is underpinned by sector fundamentals, including a $100 billion patent cliff facing major pharma by 2028, driving acquisition demand. Backed by Schroders and over three decades of biotech investment expertise, IBT continues to deliver consistent NAV growth, stable yield, and defensive exposure to innovation-driven life sciences opportunities.

Amazing AI PLC (AAI:LSE) delivered an investor presentation highlighting its dual focus on scalable lending operations and a high-leverage digital asset treasury strategy designed to maximise upside while managing downside risk. Founder and CEO Paul Mathieson, who also provides an undrawn £5 million debt facility, outlined the company’s evolution from traditional lending under its fully regulated U.S. subsidiary, Mr. Amazing Loans, to its current push into AI-driven financial technology and digital assets. The group, which reports gross margins of around 60% from its core lending business, operates with advanced automation enabling expansion to £100 million in loans without additional staff. Its new digital asset treasury, held via Amazing AI Services in Mauritius and custodied by BitGo, deploys sophisticated derivative structures offering 100× exposure for minimal cost, targeting Bitcoin, Ethereum, XRP, Solana, and gold-backed tokens. Matheson emphasised that this institutional-level strategy, unavailable to retail investors, combines high-margin lending with leveraged digital exposure for asymmetric growth potential. The company expects full deployment of its strategy by December 2025, backed by experienced leadership including Chairman Neil Patrick. With plans to license proprietary AI underwriting technology, expand globally, and pursue acquisitions of undervalued digital treasury peers, Amazing AI PLC aims to build a diversified fintech platform blending regulated consumer lending with advanced AI and blockchain innovation.